Release Time:2025-03-26 Hits:
Date of Publication: 2024-04-25
Journal: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume: 25
Issue: 7
ISSN: 1661-6596
Key Words: CURCUMIN; EXPRESSION; HYPOXIA-INDUCIBLE FACTORS; IMMUNOTHERAPY; MOLECULE; PD-L1; TARGET
Prev One:Discovery of novel NSAID hybrids as cPLA(2)/COX-2 dual inhibitors alleviating rheumatoid arthritis via inhibiting p38 MAPK pathway.
Next One:Novel trifluoromethyl ketone derivatives as oral cPLA(2)/COX-2 dual inhibitors for resolution of inflammation in rheumatoid arthritis.